Addus HomeCare (NASDAQ:ADUS) EVP Sells $86,395.20 in Stock

Addus HomeCare Corporation (NASDAQ:ADUS) EVP Brian Poff sold 820 shares of the stock in a transaction dated Wednesday, February 25th. The stock was sold at an average price of $105.36, for a total transaction of $86,395.20. Following the transaction, the executive vice president directly owned 63,692 shares of the company’s stock, valued at $6,710,589.12. This represents a 1.27% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Brian Poff also recently made the following trade(s):

• On Tuesday, February 24th, Brian Poff sold 2,041 shares of Addus HomeCare stock. The shares were sold at an average price of $106.98, for a total value of $218,346.18.

Addus HomeCare Stock Performance

Shares of ADUS stock opened at $103.53 on Friday. The company has a market cap of $1.92 billion, a price-to-earnings ratio of 19.87, a price-to-earnings-growth ratio of 1.44 and a beta of 0.91. The stock has a 50 day simple moving average of $109.22 and a 200-day simple moving average of $112.95. Addus HomeCare Corporation has a 12-month low of $88.96 and a 12-month high of $124.43. The company has a current ratio of 1.80, a quick ratio of 1.66 and a debt-to-equity ratio of 0.11.

Hedge Funds Weigh In On Addus HomeCare

Several institutional investors have recently added to or reduced their stakes in ADUS. Global Retirement Partners LLC boosted its stake in Addus HomeCare by 395.7% in the 4th quarter. Global Retirement Partners LLC now owns 233 shares of the company’s stock worth $25,000 after buying an additional 186 shares during the last quarter. Larson Financial Group LLC increased its stake in shares of Addus HomeCare by 133.3% during the 3rd quarter. Larson Financial Group LLC now owns 238 shares of the company’s stock valued at $28,000 after acquiring an additional 136 shares during the last quarter. Acumen Wealth Advisors LLC purchased a new position in shares of Addus HomeCare during the 4th quarter worth about $29,000. Private Trust Co. NA boosted its position in shares of Addus HomeCare by 65.5% in the fourth quarter. Private Trust Co. NA now owns 283 shares of the company’s stock worth $30,000 after acquiring an additional 112 shares during the last quarter. Finally, Arax Advisory Partners boosted its position in shares of Addus HomeCare by 95.8% in the fourth quarter. Arax Advisory Partners now owns 280 shares of the company’s stock worth $30,000 after acquiring an additional 137 shares during the last quarter. 95.35% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

ADUS has been the subject of a number of recent analyst reports. Royal Bank Of Canada reissued an “outperform” rating and issued a $139.00 target price on shares of Addus HomeCare in a report on Wednesday. BMO Capital Markets assumed coverage on shares of Addus HomeCare in a report on Thursday, November 13th. They issued a “market perform” rating and a $120.00 price target for the company. TD Cowen reissued a “buy” rating on shares of Addus HomeCare in a report on Wednesday, November 5th. Stephens lowered their target price on shares of Addus HomeCare from $140.00 to $135.00 and set an “overweight” rating on the stock in a research report on Wednesday. Finally, Weiss Ratings reiterated a “hold (c+)” rating on shares of Addus HomeCare in a research report on Wednesday, January 21st. One research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $134.33.

Key Stories Impacting Addus HomeCare

Here are the key news stories impacting Addus HomeCare this week:

• Positive Sentiment: Large institutional holders have been adding to positions in recent quarters, which provides a steady shareholder base and underlying demand. MarketBeat ADUS Institutional Holdings
• Positive Sentiment: Stephens kept an “Overweight” rating on ADUS and a $135 price target (trimmed from $140), signaling continued analyst conviction even after the cut. That backing can limit downside over the medium term. Stephens PT story
• Neutral Sentiment: Short‑interest figures are inconsistent across feeds (some reports show zero or NaN, others show a material rise). This data noise makes it hard to interpret immediate short pressure — confirm with FINRA/exchange data before acting. MarketBeat short interest
• Negative Sentiment: Significant insider selling across Feb. 24–25: CEO R. Dirk Allison and multiple EVPs sold several thousand shares in aggregate (CEO filings disclosed to the SEC). Large, concentrated insider sales are weighing on sentiment and likely contributed to today’s weakness. CEO SEC filing
• Negative Sentiment: Media flagged a “pessimistic forecast” narrative after Stephens trimmed its target, which can reinforce short‑term selling despite the retained Overweight rating. That coverage likely amplified intra‑day pressure. AmericanBankingNews piece
• Negative Sentiment: Smaller insider sales (e.g., EVP Cliff Blessing) were also reported; while individually minor, the wave of coordinated filings increases headline risk and may trigger mechanical selling. InsiderTrades alert

About Addus HomeCare

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.